UiPath is expanding its partnership with Deloitte through the professional services company's new Agentic ERP offering.

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for a slowdown in full-year revenue growth.

UiPath Inc PATH reported better-than-expected financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. The company reported revenue of $481.11 million versus ...

UiPath is looking to become an AI agent orchestration platform. The company's roots in RPA give it a strong foundation to become a leading agentic AI orchestration platform. The stock is very cheap at ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. UiPath (NYSE:PATH) has agreed to acquire WorkFusion, a ...

UiPath, Inc. (NYSE:PATH) is one of the Best All-Time Low Stocks to Invest In Now. On February 23, UiPath, Inc. (NYSE:PATH), which is a leader in robotic process automation, launched new AI tools, ...

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

UiPath Inc. is rated a strong buy, with a price target near $18, following a 30% sell-off driven by AI-related sector fears. PATH's robust AI-driven automation platform, strong earnings beats, and 16% ...

Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...